Compare ATRC & STBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | STBA |
|---|---|---|
| Founded | 2000 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2005 | 1995 |
| Metric | ATRC | STBA |
|---|---|---|
| Price | $28.17 | $45.08 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 6 |
| Target Price | ★ $51.17 | $43.00 |
| AVG Volume (30 Days) | ★ 769.9K | 239.3K |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.29% |
| EPS Growth | ★ 74.74 | 2.35 |
| EPS | N/A | ★ 0.94 |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $15.27 | $10.20 |
| Revenue Next Year | $12.21 | $4.14 |
| P/E Ratio | ★ N/A | $47.87 |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.52 | $34.01 |
| 52 Week High | $43.18 | $45.17 |
| Indicator | ATRC | STBA |
|---|---|---|
| Relative Strength Index (RSI) | 49.86 | 61.23 |
| Support Level | $26.47 | $42.25 |
| Resistance Level | $30.75 | N/A |
| Average True Range (ATR) | 1.36 | 0.81 |
| MACD | 0.20 | 0.04 |
| Stochastic Oscillator | 69.14 | 87.53 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.